Trinanjan Basu

Trinanjan Basu

Radiation Oncologist

Radiation Oncology

HCG Cancer Centre

Location India, Mumbai

Linkedin

X

Dr. Trinanjan Basu is a Senior Consultant and Head of Department in Radiation Oncology specializing in head & neck, genitourinary, colorectal, lymphoma, bone & soft tissue sarcoma, and lung cancers. He currently practices at HCG Cancer Hospital, Borivali, and HCG Cancer Center, Colaba, Mumbai. His work focuses on IMRT/VMAT for head and neck cancers and SRS/SBRT (300+ cases) for brain, spine, lung, and prostate cancers, with an emphasis on PET-CT-based treatment planning and quality-of-life outcomes for patients. He has treated over 5,000 patients across his 15-year career and has received multiple international fellowships and grants, including the ESTRO Mobility Grant, the AROI-International Travel Grant, and the Neil Joseph Award.

Current Position

  • Senior Consultant and Head of Department, Radiation Oncology — HCG Cancer Hospital, Borivali, Mumbai
  • Consultant, Radiation Oncology — HCG Cancer Center, Colaba, Mumbai

Education

  • MBBS
  • MD, Radiation Oncology
  • CAS-Pr — Switzerland
  • Advanced studies in prostate cancer certification — European School of Oncology (ESO)

Professional Experience

  • 14–15 years of clinical experience in radiation oncology
  • Treated 5,000+ patients across diverse cancer types
  • Clinical observership in Prostate SBRT and sarcoma multidisciplinary management — National Cancer Centre, Singapore (December 2018)
  • Clinical rotation — Institut Gustave Roussy (iGR), Paris, and Orsay Proton Therapy Centre (via ESTRO Mobility Grant)
  • Observership program — Tata Memorial Hospital, Mumbai (Neil Joseph Award)

Areas of Specialization

  • Head and neck cancer
  • Genitourinary cancer
  • Colorectal cancer
  • Lymphoma
  • Bone and soft tissue sarcoma
  • Lung cancer
  • IMRT/VMAT for head and neck cancers
  • SRS/SBRT for brain, spine, lung, and prostate cancers
  • PET-CT-based treatment planning

Memberships / Honors / Awards

  • Member, Society of Genitourinary Oncology
  • Member, GI Oncology Executive Committee
  • Member, ASCO TECAG (Trainee and Early Career Advisory Group)
  • Member, ASTRO Training and Education Committee
  • Neil Joseph Award — observership program at Tata Memorial Hospital, Mumbai
  • ESTRO Mobility Grant — Institut Gustave Roussy (iGR), Paris, and Orsay Proton Therapy Centre
  • Travel grant and course, ESO-ESTRO Radiation Oncology Masterclass — Cascais, Portugal
  • ESMO Translational Research Grant — University of Vienna
  • ESMO Preceptorship Travel Grant — Zurich and Singapore
  • AROI-International Travel Grant
  • Advanced studies in prostate cancer certification — European School of Oncology (ESO)

Publications

Dr. Trinanjan Basu has more than 35 national and international publications in peer-reviewed journals, including book chapters, with research spanning radiation oncology techniques, head and neck cancer management, stereotactic body radiotherapy, prostate cancer outcomes, and toxicity management in radiotherapy. Selected recent publications are listed below.

Selected Recent Publications

Menon RR, Basu T, Sahu JP, Kamat SJ, Roshan GK, Gadekar AU, et al. Treatment outcomes in p16-negative oropharyngeal squamous cell carcinoma (OPSCC): A real-world retrospective data from a low-middle income country (LMIC). European Archives of Oto-Rhino-Laryngology 283(2), 1121-1128. 2026.
Basu T, Menon RR, Sahu JP, Roshan GK. Chemoradiation for HPV-Negative Oropharyngeal Cancer: What Have We Achieved? IntechOpen. 2025.
Basu T, Sahu JP, Roshan G, Menon RR, Kamat S, Gadekar AU, et al. Toxicity and Quality of Life (QOL) Outcomes of Short Course Radiotherapy (SCRT) by Intensity Modulated Radiotherapy (IMRT) in Rectal Cancer–Institutional Prospective Database. International Journal of Radiation Oncology, Biology, Physics 123(1), e139-e140. 2025.
Basu T, Sahu JP, Kamat S, Menon RR, Roshan G, Nair R, Gawde S, et al. PSA and PSMA Kinetics for Intermediate Risk, High-Very High Risk and Oligometastatic Prostate Cancer Patients Treated by Moderate Hypofractionated Radiotherapy (MHRT) and SBRT. International Journal of Radiation Oncology, Biology, Physics 123(1), e534. 2025.
Kurkure D, Kamat S, Basu T, Sahu JP, Nair R, Kaskar A, Patil RB, et al. Single Institution Experience of Volumetric Modulated Arc Based Total Body Irradiation (VMAT-TBI). International Journal of Radiation Oncology, Biology, Physics 123(1), e748-e749. 2025.
Basu T, Sahu JP, Kamat SJ, Menon RR, Gadekar AU, Roshan GK. Expanding Role of SBRT in Primary Bladder Cancer–Is It Ready for Prime Time? Diseases & Research 5(3), 157-159. 2025.
Basu T, Sahu JP, Roshan G, Kamat S, Menon R. 239P Institutional prospective database of short-course radiotherapy (SCRT) by intensity modulated radiotherapy (IMRT) in rectal cancer: Toxicity and quality of life (QOL) outcomes. Annals of Oncology 36, S95. 2025.
Basu T, Sahu JP, Gadekar A, Kamat SJ, Menon R, Roshan GK, Nair RG, et al. 1614 Prospective evaluation of sexual quality of life (QOL) among high-risk prostate cancer treated by SBRT and androgen deprivation therapy (ADT). Radiotherapy and Oncology 206, S1958-S1959. 2025.
Sahu JP, Basu T, Menon RR, Roshan GK, Gadekar A, Kamat SJ, et al. 1619 Geriatric head and neck squamous cell carcinomas (GHNC) treated with modulated radiotherapy (MRT): Preliminary single Institution outcome. Radiotherapy and Oncology 206, S983-S984. 2025.
Kamat SJ, Basu T, Sahu JP, Menon RR, Gadekar A, Roshan GK, et al. PACE A and PACE B trial–What a radiation oncologist needs to know. Journal of Radiosurgery and SBRT 9(3), 257. 2025.
Sahu JP, Basu T, Kamat SJ, Gadekar A, Menon RR, Roshan GK. Effect of stereotactic body radiotherapy beyond primary target in prostate cancer. Journal of Radiosurgery and SBRT 9(3), 253. 2025.
Basu T, Sahu JP, Kamat S, Menon R, Roshan G, Gadekar AU, Nair R. Patient Reported Quality of Life (QOL) Outcomes for Intermediate-High Risk-Very High-Risk Prostate Cancers Treated by SBRT and Androgen Deprivation Therapy (ADT). International Journal of Radiation Oncology, Biology, Physics 120(2), e513. 2024.
Basu T, Sahu JP, Gnair R, Kamat SJ. Preliminary results of sexual quality of life (QOL) outcome for intermediate-high risk prostate cancers treated by stereotactic radiotherapy (SBRT) and androgen deprivation therapy. Journal of Clinical Oncology 42(16_suppl), e17085-e17085. 2024.
Chilukuri S, Mallick I, Agrawal A, Maitre P, Arunsingh M, James FV, et al. Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy. Clinical Oncology 35(7), 454-462. 2023. 3 Citations.
Basu T. SBRT (Stereotactic Body Radiotherapy) in Recurrent Head Neck Cancer–Boon or Bane? Qeios. 2023.
Basu T, Senapati MR, Karpe A, Priyadharshni JM, Nair R, Rajurkar S, et al. Safety, Efficacy and Quality of Life with Stereotactic Radiotherapy (SBRT) in High Risk, Node Positive and Oligometastatic Prostate Cancers. Cureus Journal of Medical Science 15(4). 2023.
Basu T, Mahuvakar A, Karpe A. Towards a comprehensive head-and-neck oncological radiology (HNOR) consortium: Are we there yet? Cancer Research, Statistics, and Treatment 6(1), 148-149. 2023.
Basu T, Senapati MR, JM Priyadharshni, Karpe A, Gawde S, Gnair R, et al. Simultaneous integrated boost (SIB) stereotactic body radiotherapy (SBRT) for prostate and pelvic nodes in high risk, node positive and oligometastatic prostate cancers: Safety. Journal of Clinical Oncology 41(6_suppl), 121-121. 2023.
Saxena U, Senapati MR, Basu T, Rajurkar S, Raut N, Karpe A, Joshi A, et al. Comparison of Short Term Clinical and Dosimetric Outcomes of Fast Forward vs. Hypofractionated Radiotherapy for Early Breast Cancer–A Single Center Experience. International Journal of Radiation Oncology, Biology, Physics 114(3), e10-e11. 2022. 1 Citation.
Basu T, Senapati MR, Priyadharshni JM, Nair R, Saxena U, Rajurkar S. 94P Preliminary outcome data for deep inspiratory breath hold guided stereotactic radiotherapy (SBRT) with robotic couch correction for early stage non-small cell lung cancers. Annals of Oncology 33, S76. 2022. 1 Citation.
Senapati MR, Basu T, Saxena U, Eddam RK, Maxwell S, Rajurkar S, et al. Simultaneous Integrated Boost (SIB) Stereotactic Body Radiotherapy (SBRT) for prostate and pelvic nodes in high risk, node positive and oligometastatic prostate cancers: Safety. European Urology Open Science 45, S135. 2022.
Saxena U, Basu T, Senapati MR, Saran DS, Rajurkar S, Patil RB, et al. Single Institute Experience–Linear Accelerator Based Total Body Irradiation Using Volumetric Modulated Arc Therapy Planning in Standard Size Linear Accelerator Room. International Journal of Radiation Oncology, Biology, Physics 114(3), e356-e357. 2022.
Basu T, Senapati MR, Karpe A, Mahuvakar A, Mathur Y, Ambulkar I, et al. Preliminary Outcome and Quality of Life among Geriatric Head and Neck Cancer (GHNC) Patients Treated with Institutional Nimorad (Nimotuzumab-Modulated Radiotherapy) Protocol. International Journal of Radiation Oncology, Biology, Physics 114(3), e450. 2022.
Basu T, Senapati MR, Saxena U, Rajurkar S, Mathur Y, Mahuvakar A, et al. Carotid Sparing Modulated Radiotherapy (CSMRT) for Early Glottic Cancers: Single Institution Feasibility and Safety Assessment. International Journal of Radiation Oncology, Biology, Physics 114(3), e307. 2022.
Basu T, Senapati MS. Preliminary results of Stereotactic Radiotherapy (SBRT) for Oligometastatic prostate cancer: Single institute experience. European Urology Open Science 39, S56. 2022.
Murthy V, Chilukuri S, Mallick I, Maitre P, Agarwal A, Moses AS, James F, et al. OC-0606 Multi-institutional outcomes of Gleason grade group 5 prostate cancers treated with EBRT and ADT. Radiotherapy and Oncology 170, S531-S532. 2022.
Basu T, Kataria T, Goyal S, Gupta D. Preliminary Analysis of CyberKnife Stereotactic Radiotherapy for Primary and Recurrent Head and Neck Cancers: A Delicate Balance. International Journal of Head and Neck Surgery 12(2), 43-47. 2021.
Basu T, Karpe A, Gawde S, Gajenji A. Preliminary results of patient reported quality of life outcome from moderate and extreme hypofractionation for localised prostatic adenocarcinoma. European Urology Open Science 21, S129. 2020.
Basu T, Ambulkar I, Nayek D, Karpe A, Gawde S, Kamwal B, Shah S, et al. Outcome and Quality of Life among Geriatric Head and Neck Cancer Patients Treated with Intensity Modulated Radiotherapy: Importance of Comprehensive Geriatric Head and Neck Assessment. International Journal of Radiation Oncology, Biology, Physics 108(3), e226. 2020.
Basu T, Karpe A, Mathur Y, Patel A, Kendre P, Katna R, Raut N, et al. 937P Outcome, patterns of failure and toxicity profile following adjuvant intensity modulated radiotherapy for oral cavity squamous cell carcinomas. Annals of Oncology 31, S671. 2020.
Basu T, Bhaskar N. Overview of important “organs at risk” (OAR) in modern radiotherapy for head and neck cancer (HNC). Cancer Survivorship 1. 2019. 18 Citations.
Basu T, Karpe A, Kendre P, Nayek D, Rao S, Ambulkar IB. Geriatric head and neck squamous carcinomas treated with modulated radiotherapy: Learning curve. Journal of Global Oncology 5(suppl), 107-107. 2019.
Basu T, Bhaskar P, Gawde S, Karpe A, Bhange A, Saxena U, Armugam K, et al. Definitive Treatment with Adaptive Modulated Simultaneous Integrated Boost Radio(chemo)Therapy for Locally Advanced Non Metastatic Squamous Cell Carcinomas of Head and Neck. International Journal of Radiation Oncology, Biology, Physics 105(1), E411. 2019.
Basu T, Bhaskar N, Armugam K, Ganeshan P, Saxena U. Clinical and dosimetric correlation between nausea-vomiting, fatigue and late dysphagia related to nervous system structures during radical radiotherapy for squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics 105(1), E410-E411. 2019. 2 Citations.
Basu T, Karpe A, Kendre P, Bhaskar P, Sharnanghat V, Gawde S, Kasat A, et al. Single institution preliminary analysis of geriatric head and neck squamous carcinomas treated with modulated radiotherapy. Journal of Clinical Oncology 37(15_suppl), e17566-e17566. 2019.
Basu T, Goyal S, Kataria T, Gupta D. Head-and-neck cancer patients beyond 2 years of disease control: Preliminary analysis of intensity-modulated radiotherapy late-effect assessment scale. Journal of Cancer Research and Therapeutics 15(3), 696-699. 2019.
Banerjee S, Kataria T, Gupta D, Goyal S, Bisht SS, Basu T, Abhishek A. Use of ultrasound in image-guided high-dose-rate brachytherapy: enumerations and arguments. Journal of Contemporary Brachytherapy 9(2), 146-150. 2017. 40 Citations.
Kataria T, Basu T, Gupta D. Treatment of Head and Neck cancers with modulated radiation at an Indian Centre. International Conference on Advances in Radiation Oncology (ICARO2), Book of Proceedings. 2017.
Kataria T, Basu T, Goyal S, Gupta D, Nasreen S, Bisht SS, Abhishek A, et al. Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data. Indian Journal of Medical and Paediatric Oncology 38(04), 495-501. 2017.
Kataria T, Gupta D, Bisht SS, Basu T, Abhishek A, Narang K, Goyal S, et al. Quantification of coronary artery motion and internal risk volume from ECG-gated radiotherapy planning scans. Radiotherapy and Oncology 121(1), 59-63. 2016. 37 Citations.
Kataria T, Gupta D, Goyal S, Bisht SS, Chaudhary R, Narang K, Basu T, et al. Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: an MRI based approach. British Journal of Radiology 89(1068), 20160348. 2016. 33 Citations.
Kataria T, Gupta D, Goyal S, Bisht SS, Goyal S, Basu T, et al. Clinical outcomes of adaptive radiotherapy in head and neck cancers. British Journal of Radiology 89(1062), 20160085. 2016. 58 Citations.
Kataria T, Narang K, Bisht SS, Abhishek A, Goyal S, Basu T, Karrthick KP. Analysis of intrafraction motion in CyberKnife-based stereotaxy using mask based immobilization and 6D-skull tracking. Journal of Radiosurgery and SBRT 4(3), 203. 2016. 17 Citations.
Kataria T, Gupta D, Basu T, Gupta S, Goyal S, Banerjee S, Abhishek A, et al. Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan. British Journal of Radiology 89(1058), 20150661. 2016. 6 Citations.
Abhishek A, Kataria T, Gupta D, Basu T, Bisht SS, Goyal S, Karrthick KP. Portal vein tumor thrombus irradiation: paving the way for liver transplant. International Journal of Radiation Oncology, Biology, Physics 96(2), E164. 2016. 3 Citations.
Kataria T, Mishra SR, Gupta D, Goyal S, Bisht SS, Malik A, Abhishek A, et al. Modulated radiotherapy for head and neck carcinomas: An outcome study. Journal of Radiotherapy in Practice 17(4), 384-389. 2018. 1 Citation.
Engineer R, Basu T, Chopra S, Arya S, Patil P, Mehta S, Ramadwar M, et al. Factors influencing response to neoadjuvant chemoradiation and outcomes in rectal cancer patients: tertiary Indian cancer hospital experience. Journal of Gastrointestinal Oncology 6(2), 155. 2015. 27 Citations.
Kataria T, Gupta D, Bisht SS, Goyal S, Basu T, Srivastava A, Abhishek A, et al. Chemoradiation in elderly patients with head and neck cancers: a single institution experience. American Journal of Otolaryngology 36(2), 117-121. 2015. 23 Citations.
Laskar SG, Basu T, Chaudhary S, Chaukar D, Nadkarni M, Gn M. Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale. Journal of Contemporary Brachytherapy 6(4), 350-355. 2015. 19 Citations.
Basu T, Kataria T, Goyal S, Abhishek A, Gupta D, Subramani V, et al. Preliminary results of CyberKnife stereotactic radiotherapy (SBRT) boost for primary head and neck cancers: is it the future direction? Journal of Radiotherapy in Practice 14(2), 187-193. 2015. 6 Citations.
Goda JS, Pachpor T, Basu T, Chopra S, Gota V. Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers. Indian Journal of Medical Research 143(2), 145-159. 2016. 20 Citations.
Basu T, Laskar SG, Gupta T, Budrukkar A, Murthy V, Agarwal JP. Toxicity with radiotherapy for oral cancers and its management: A practical approach. Journal of Cancer Research and Therapeutics 8(Suppl 2), S72-S84. 2012. 61 Citations.